Demonstrating an AI framework they developed, the Jaklenec and Langer Labs designed shelf-stable mRNA vaccines that could make treatments for Covid-19, cancer, and many other diseases more accessible. Described in Nature Biotechnology, the heat-tolerant mRNA vaccine could be distributed in places that lack expensive cold-chain infrastructure and adapted for novel administration methods, such as microneedle patches.